comparemela.com

Latest Breaking News On - Minimally invasive technologies group - Page 1 : comparemela.com

Medtronic (MDT) Receives a Buy from Bank of America Securities

In a report released yesterday, Travis Steed from Bank of America Securities reiterated a Buy rating on Medtronic (MDT – Research Report),.

United statesRestorative therapies groupMedtronic plcBecton dickinsonBoston scientificInvasive technologies groupDiabetes groupBaxter internationalVascular groupTravis steedAmerica securitiesResearch reportModerate buyHoedt rob tenGlobal regionsMinimally invasive technologies group

Truist Financial Remains a Hold on Medtronic (MDT)

In a report released on July 12, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The.

United statesRichard newitterIntegra lifesciencesMedtronic plcVascular groupInvasive technologies groupDiabetes groupRestorative therapies groupBoston scientificTruist financialResearch reportModerate buyHoedt rob tenGlobal regionsMinimally invasive technologies group

RBC Capital Keeps Their Hold Rating on Medtronic (MDT)

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Medtronic (MDT – Research Report) on July 12 and set a price target of.

Edwards lifesciencesShagun singh chadhaSingh chadhaMedtronic plcRestorative therapies groupDiabetes groupVascular groupInvasive technologies groupResearch report onNevro corpResearch reportModerate buyHoedt rob tenGlobal regionsMinimally invasive technologies group

Positive Report for Medtronic (MDT) from Credit Suisse

Credit Suisse analyst Lorenzo Biasio upgraded Medtronic (MDT – Research Report) to a Buy yesterday and set a price target of $92.00. The c.

Morgan stanley ceciliaCoherus biosciencesLorenzo biasioEdwards lifesciencesCredit suisseRestorative therapies groupVascular groupInvasive technologies groupMedtronic plcDiabetes groupResearch reportMorgan stanleyCecilia furlongTruist financialMinimally invasive technologies group

BTIG Sticks to Its Hold Rating for Medtronic (MDT)

BTIG analyst Ryan Zimmerman maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $350.00. The com.

Ryan zimmermanMorgan stanley ceciliaWells fargoRestorative therapies groupInvasive technologies groupMedtronic plcDiabetes groupVascular groupResearch reportMorgan stanleyCecilia furlongMinimally invasive technologies group

vimarsana © 2020. All Rights Reserved.